Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New transplant method aims to tame dangerous side effects in blood cancer patients

NCT ID NCT05565105

Summary

This study is testing a method to prepare donor stem cells before transplant, with the goal of reducing serious complications for adults with leukemia or lymphoma. The main focus is on lowering the risk of graft-versus-host disease, where donor cells attack the patient's body, and other transplant-related problems. Researchers will track survival, disease recurrence, and how well patients tolerate the processed cells.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA, MYELOID, ACUTE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baptist Health South Florida/Miami Cancer Institute

    Miami, Florida, 33176, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.